Related Experiment Video
Updated: Jul 6, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Embolic protection in infrainguinal interventions
1Division of Vascular Surgery, Saint Louis University Health Sciences Center, St. Louis, Missouri 63110, USA. bpeters1@slu.edu
Insights
Embolic protection devices (EPDs) show benefits in some vascular interventions, but their use in lower limb endovascular procedures requires further investigation to identify optimal patient candidates.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Medical Devices
Background:
- Embolic protection devices (EPDs) are established in coronary and carotid interventions.
- Their efficacy in infrainguinal endovascular interventions remains uncertain.
- Potential benefits exist for specific patient subgroups or procedures.
Purpose of the Study:
- To review the current literature on EPD use in infrainguinal endovascular interventions.
- To identify patient populations likely to benefit from off-label EPD application.
- To provide guidelines and stimulate research for lower extremity revascularization.
Main Methods:
- Literature review of embolic protection devices in infrainguinal interventions.
- Analysis of patient-specific and lesion-specific factors.
- Description of institutional experience with EPDs.
Main Results:
- Evidence for EPD utility in infrainguinal interventions is limited.
- Specific anatomical or lesion characteristics may indicate benefit.
- Further clinical trials are needed to confirm efficacy.
Conclusions:
- The role of EPDs in infrainguinal endovascular interventions needs further clarification.
- Identifying ideal candidates for off-label EPD use is crucial.
- Future research should focus on lower extremity endovascular revascularization outcomes with EPDs.
Abstract:
The benefits of the use of embolic protection devices (EPDs) in saphenous vein coronary artery bypass grafts and carotid arteries have been shown, but the utility of their application during infrainguinal endovascular interventions is somewhat unclear. Patients with specific anatomical features or lesion characteristics, or patients undergoing specific types of endovascular interventions may benefit from the off-label use of EPDs, but this has yet to be determined. This report will examine the current literature related to the use of EPDs in infrainguinal endovascular interventions and attempt to identify the patients who would most likely benefit from their use. In addition, the setting in which EPDs have been used at one institution is briefly described. This discussion will serve as a general guideline for the use of EPDs and act as an impetus for the development of future clinical trials to help elucidate the patients who will truly benefit from EPDs use when undergoing lower extremity endovascular revascularization procedures.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
